Overview |
bsm-41488M |
SARS-CoV-2 Nucleocapsid monoclonal Antibody |
ELISA |
SARS-CoV-2 |
Specifications |
Unconjugated |
Mouse |
Recombinant SARS-CoV-2 Nucleocapsid Protein:1-419/419 |
1-419/419 |
Monoclonal |
8C8 |
IgG2a |
1mg/ml |
Purified by Protein G. |
Aqueous buffered solution containing 0.01M PBS(pH7.4) with 0.1% Proclin300. |
Store at -20°C for 12 months. |
Target |
43740575 |
P0DTC9 |
SARS-CoV-2 Nucleocapsid Protein; SARS-CoV-2 NP; nucleocapsid protein [Severe acute respiratory syndrome coronavirus 2]; novel coronavirus N Protein; novel coronavirus Nucleocapsid Protein; 2019-nCoV Nucleoprotein; 2019-nCoV N; 2019nCoV N; 2019-nCoV N Protein; 2019 ncov N Protein; 2019-nCoV nucleocapsid protein. |
Coronaviruses are enveloped viruses with a positive-sense RNA genome and with a nucleocapsid of helical symmetry. Coronavirus nucleoproteins localize to the cytoplasm and the nucleolus, a subnuclear structure, in both virus-infected primary cells and in cells transfected with plasmids that express N protein. Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. During virion assembly, N protein binds to viral RNA and leads to formation of the helical nucleocapsid. Nucleocapsid protein is a highly immunogenic phosphoprotein also implicated in viral genome replication and in modulating cell signaling pathways. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool. |
Application Dilution |
ELISA |
1:500-1000 |